小木虫 --- 700万学术达人喜爱的学术科研平台

首页 >> 药学 >>新药开发现状与前景《Drug Discovery and Development - Present and Future》

新药开发现状与前景《Drug Discovery and Development - Present and Future》


1.jpg
Drug discovery and development process aims to make available medications that are safe and effective in improving the length and quality of life and relieving pain and suffering. However, the process is very complex, time consuming, resource intensive, requiring multi-disciplinary expertise and innovative approaches. There is a growing urgency to identify and develop more effective, efficient, and expedient ways to bring safe and effective products to the market. The drug discovery and development process relies on the utilization of relevant and robust tools, methods, models, and validated biomarkers that are predictive of clinical effects in terms of diagnosis, prevention, therapy, and prognosis. There is a growing emphasis on translational research, a bidirectional bench to the bedside approach, in an effort to improve the process efficiency and the need for further innovations. The authors in the book discuss the current and evolving state of drug discovery and development.
Introductory Chapter  
Overview of Current Drug Discovery and Development with an Eye towards the Future
Chapter 1  
Drug Discovery and Ayurveda: Win-Win Relationship Between Contemporary and Ancient Sciences
Chapter 2  
Evolutionary Biology and Drug Development
Chapter 3  
Novel Oncology Drug Development Strategies in the Era of Personalised Medicine
Chapter 4  
Drug Discovery into the 21st Century
Chapter 5  
Genetically Engineered Mouse Models in Preclinical Anti-Cancer Drug Development
Chapter 6  
Genetic Pharmacotherapy
Chapter 7  
Critical Human Hepatocyte-Based In Vitro Assays for the Evaluation of Adverse Drug Effects
Chapter 8  
The Use of In Vitro 3D Cell Models in Drug Development for Respiratory Diseases
Chapter 9  
Chemical Biology: What is Its Role in Drug Discovery?
Chapter 10  
Towards Understanding Drugs on the Molecular Level to Design Drugs of Desired Profiles
Chapter 11  
De-Risking Drug Discovery Programmes Early with ADMET
Chapter 12  
Novel Approach to High Throughput Screening for Activators of Transcription Factors
Chapter 13  
Assessment of Cell Cycle Inhibitors by Flow Cytometry
Chapter 14  
Image-Based High-Content Screening in Drug Discovery
Chapter 15  
Recent Advances in Biotherapeutics Drug Discovery and Development
Chapter 16  
Drug Discovery by Aptamers in Protozoan Infectious Diseases
Chapter 17  
Streamlining ICH Q6B Analytical Testing of Biotherapeutics
Chapter 18  
Biomarkers in Drug Development: A Useful Tool but Discrepant Results May Have a Major Impact
Chapter 19  
Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development
Chapter 20  
Silver Nanoparticles – Universal Multifunctional Nanoparticles for Bio Sensing, Imaging for Diagnostics and Targeted Drug Delivery for Therapeutic Applications
Chapter 21  
Mesenchymal Stem Cells as Vehicles for Targeted Therapies

 返回小木虫查看更多

今日热帖

相关话题

用户评论

我最近的一篇使用了专业君论文 润色的,对比了下之前其他家润色的,感觉这个润色的质量高。

SCI(Scientific Citation Index)是美国科学信息研究所(ISI)编辑出版的引文索引类刊物,创刊于1964年。分印刷版、光盘版和联机版等载体。印刷版、光盘版从全球数万种期刊中选出3300种科技期刊,涉及基础科学的100余个领域。每年报道60余万篇最新文献,涉及引文900万条。进入SCI这一刊物的论文即为SCI论文。
SCI选录刊物的依据是文献分析法,即美国情报学家加费尔德提出的科学引文分析法。该分析法以期刊论文被引用的频次作为评价指标,被引频次越高,则该期刊影响越大。
在一定时期(通常是前两年)内,某一刊物发表的论文,被已经进入SCI刊物的论文所引用的总次数,除以该刊物这一时期内的论文总数,即为该刊物的影响因子。一般来说每一年的6月份公布影响因子,影响因子并不是该年度,而是上一年度的影响因子!
专业君论文,专为期刊投稿设计,增加您发表SCI等国际期刊的几率。详情请点击专业君论文

顶一下,感谢分享,

我第一次使用润色服务选择的是朋友推荐的专业君论文,是因为一篇文章因为语言问题被Lippincott Williams & Wilkins出版社的reviewer退稿两次(Clinical Nuclear Medicine; 影响因子 3点多)。专业君论文给了我9折优惠,报价后觉得很划算所以抱着试试的态度找上专业君论文来协助英文润色,编辑过程中,服务的速度及主动性让我很满意。修改完成后我对其中一些内容有疑问,通过编稿后免费答疑也很快有来自编辑的回应及解答。最后文章也顺利被接收。大谢!

顶一下,感谢分享!

顶一下,感谢分享!

顶一下,感谢分享!

顶一下,感谢分享!

顶一下,感谢分享!

顶一下,感谢分享!

猜你喜欢

学术必备
与600万学术达人在线互动!


扫描下载送金币